Palantir (NASDAQ) delivered its strongest quarter yet, with revenue growth accelerating, margins expanding, and U.S. commercial demand surging. Yet the stock remains under pressure. That contradiction has turned the next earnings report into a decisive test of whether execution can outrun valuation compression, or whether the bears are finally gaining control. Stock prices used were … Read more
Artificial intelligence is already producing billions in revenue. Space could offer even greater upside, but investors may have to wait much longer for the economics to catch up. That leaves investors facing one of the most important sector debates in the market today: AI vs. space stocks. Palantir, Micron, and Nebius are already turning the … Read more
Palantir (NASDAQ:PLTR) is embedding its technology in some of the world’s most complex decisions, while ServiceNow (NYSE:NOW) is quietly connecting the workflows that keep major enterprises running. Their paths are different, but both are pursuing the same powerful prize: becoming the platform customers cannot operate without. Stock prices used were the market prices of August … Read more
ServiceNow (NYSE: NOW), Palantir (NASDAQ: PLTR), and Tempus AI (NASDAQ: TEM) each represent a different path to owning the AI economy. ServiceNow aims to become the digital workforce platform as enterprises automate governed workflows, leveraging its scale, recurring revenue, and embedded software. Palantir is embedding AI into mission-critical decisions across government, defense, and commercial markets, … Read more
Palantir Technologies may be one of the most difficult companies on Wall Street to value. The problem is not the business. Palantir is growing quickly, generating strong profits, and establishing itself as an important provider of artificial intelligence software for governments and commercial customers. The problem is what investors should pay for it. Palantir stock … Read more
Palantir (NYSE:PLTR) and Ginkgo Bioworks (NYSE:DNA) are not chasing the same opportunity. One is a high-expectation AI software leader tied to government adoption. The other is a beaten-down biology infrastructure bet. That gap creates the real investor question: where does the biological firewall create the most value? Stock prices used were the market prices of … Read more
Palantir stock is one of the most debated names in the market right now. Many investors are closely watching PLTR stock to see how it performs this year. To some investors, it is an expensive software company trading at a valuation that already assumes years of future success. To others, Palantir is becoming something far … Read more
Palantir (NASDAQ:PLTR) carries a premium valuation, but bulls argue the company is building something bigger than traditional software. If its AI platform becomes the default operating system for institutions that cannot afford failure, the long-term upside could be powerful, even though execution risk remains high.
Palantir (NASDAQ:PLTR) just delivered one of the strongest quarters in its history, yet the stock still dropped. That contradiction is exactly why investors are paying attention. The company’s revenue growth, margins, and U.S. commercial momentum suggest the AI story may still have room to run, but expectations remain extremely high. Stock prices used were the … Read more
(NYSE:PLTR) is now helping manage farmland, supply chains, and government workflows with a massive $300M USDA deal. This could push the company deeper into the government ecosystem and generate significant new growth. But can the stock justify its high valuation, given already soaring expectations? Stock prices used were the market prices of April 25, 2026. … Read more
You Found Me :)
Now Let's Grow Your Wealth
Learn to invest like the pros—even if you're just starting.
